BridgeMD
New treatment option for PTSD - Post Traumatic Stress Disorder
Official title Evaluating Evidenced Based Options for PTSD Treatment
ClinicalTrials.gov ID: NCT06733376
What this study is testing
- What it's testing
- This study will look at: How practical it is to offer another round of proven therapy. How effective different therapy options are for people who didn't respond to the first treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Are 18 years or older
- Are fluent in English
- Have experienced a Criterion A traumatic event during their lifetime
- Have a PTSD diagnosis verified via the Clinician Administered PTSD Scale for DSM-5
- Are interested in receiving evidence-based treatment for PTSD and able to attend 10 therapy sessions over the course of 2 weeks (10 days) and could...
You likely can't join if
- The index traumatic event occurred in the past month
- They are currently suicidal or homicidal (i.e., current plan and imminent intent)
- They have unmanaged psychosis or mania
- They have not been on a stable dose of psychotropic medication for at least one month at the time of the baseline assessment
- They have completed an evidence-based cognitive behavioral PTSD treatment in the past three months or are currently engaged in an evidence-based PTSD...
- They have an intellectual disability or significant cognitive impairment that would prevent them from engaging in treatment
See the full eligibility criteria
- Are 18 years or older
- Are fluent in English
- Have experienced a Criterion A traumatic event during their lifetime
- Have a PTSD diagnosis verified via the Clinician Administered PTSD Scale for DSM-5
- Are interested in receiving evidence-based treatment for PTSD and able to attend 10 therapy sessions over the course of 2 weeks (10 days) and could possibly attend another 10 sessions of a subsequent treatment...
- Are willing and able to complete self-report measures and clinician-rated assessments at multiple timepoints over the course of the study
- The index traumatic event occurred in the past month
- They are currently suicidal or homicidal (i.e., current plan and imminent intent)
- They have unmanaged psychosis or mania
- They have not been on a stable dose of psychotropic medication for at least one month at the time of the baseline assessment
- They have completed an evidence-based cognitive behavioral PTSD treatment in the past three months or are currently engaged in an evidence-based PTSD treatment (CPT, PE)
- They have an intellectual disability or significant cognitive impairment that would prevent them from engaging in treatment
- They have a serious or unstable medical illness or instability for which hospitalization may be likely within the next year
- They have an active substance use disorder (within the past three months) that would require immediate medical observation if substance was abruptly discontinued
- They are involved with current legal actions related to their index trauma
- They have a visual or auditory impairment that would prevent them from fully participating in study activities
- They, at the time of consent, appear to have extenuating life circumstances (i.e., unstable housing, no internet access, etc.) which, in the judgement of the study team, could affect the ability to deliver interventions...
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.